Stoke Therapeutics, Inc. ($STOK)
Filing Information
| Accession Number | 0001762572-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
120,000
Total Value
$0.00
P&L
+inf% (+$4,021,200.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Patient Officer | Employee Stock Option (Right to Buy) | Derivative | Feb 17, 2026 | Grant/Award | 72,000 | $0.00 | $0.00 | 72,000 | Direct | โ | View Details | |
Chief Patient Officer | Restricted Stock Units | Derivative | Feb 17, 2026 | Grant/Award | 48,000 | $0.00 | $0.00 | 48,000 | Direct | โ | View Details |